Top searches

PL

Resources

B2RLaw advised VC fund KnowledgeHub in its investment process in Genomtec S.A.

14/10/2020

B2RLaw advised VC fund KnowledgeHub on its investment process concerning Genomtec S.A. The investment value is up to EUR 1 million. Our support included conducting a due diligence analysis and negotiating the investment agreement.

KnowledgeHub is a VC fund supporting start-ups which offer unique technology with global development potential. KnowledgeHub focuses on investments in MarTech, FinTech, MedTech and DeepTech start-ups. The transaction on behalf of the fund was conducted by Krzysztof Dębowski, Managing Partner.

Genomtec is an innovative medical technology company developing and commercializing a mobile platform used in the molecular clinical diagnosis of various infectious diseases, including tests used to detect COVID-19 caused by SARS-CoV-2.

The company’s flagship project is the mobile genetic diagnostics system, Genomtec ID -a unique solution which is innovative on a global scale. The system allows for quick and precise molecular analysis outside a laboratory environment, without the involvement of qualified laboratory personnel. The system uses micro-flow technology and SNAAT® proprietary patented isothermal technology. The system’s design allows the process to be carried out in record time, i.e. up to 15 minutes, with efficacy equal to, and in some cases exceeding, the quality of PCR laboratory tests.

Szymon Syp, Ph.D. (Partner) led B2RLaw’s team on the transaction with Iga Wojtczak-Opala (Senior Associate) and Przemysław Krzemieniecki (Partner) providing support.

“We would like to thank KnowledgeHub for giving us the chance to take part in this venture capital transaction. This is another example of B2RLaw’s leading role as legal advisors in VC transactions”, commented Szymon Syp, Ph.D.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

10/01/2023

B2RLaw advises Polish unicorn DocPlanner on its acquisition of MyDr

B2RLaw has advised Polish unicorn DocPlanner on its acquisition of MyDr – DocPlanner’s first acquisition on the Polish market. Docplanner […]

MORE
02/01/2023

New Compliance 360 practice at B2RLaw

B2RLaw has established a multidisciplinary team whose aim is to support clients in monitoring and adapting their activities to the […]

MORE
28/11/2022

B2RLaw advises on the sale of award-winning Gdynia office complex

B2RLaw has advised the sellers (a Dutch company and Polish companies) on the sale of Łużycka Office Park (buildings A, […]

MORE
15/11/2022

B2RLaw advises SaaS-enabled B2B marketplace for the healthcare industry, Dentametr, on a pre-seed round with investors, which includes Octopus Ventures

B2RLaw has advised Dentametr and its founders on its pre-seed round capital raise with investors including leading investment fund Octopus […]

MORE
08/11/2022

B2RLaw advises Auxilius Pharma on capital raise to fuel groundbreaking growth to the US market

B2RLaw advised Auxilius Pharma Sp. z o.o. and its founders on a venture capital transaction related to the investment of […]

MORE
03/11/2022

B2RLaw advises Westcoast on merger to create EUR 5.5 billion ICT distributor

B2RLaw has advised the UK’s largest privately owned information and communications technology company Westcoast on Polish aspects of its merger […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close